M&A Corner
Augmented Reality Spine Surgery Platform Augmedics Scores $82.5M03 Jul 2023
Augmedics, an augmented reality surgical-navigation platform, has raised $82.5 million in Series D financing led by CPMG, with participation from... Continue Reading
|
Flywheel Secures $54M for Medical AI Imaging Platform03 Jul 2023
Minneapolis-based medical imaging data and AI platform, Flywheel, has secured $54 million in Series D funding. The funding round was... Continue Reading
|
Lilly to Buy Diabetes Cell Therapy Partner Sigilon for Just Over $300M.03 Jul 2023
Eli Lilly is set to acquire Sigilon Therapeutics in a cash deal worth over $300 million. The two companies have... Continue Reading
|
Mark Cuban Cost Plus Drug Company Partners with Male Fertility Platform03 Jul 2023
Mark Cuban’s Cost Plus Drug Company (MCCPDC) has partnered with Posterity Health to provide males with access to medications for... Continue Reading
|
Headspace, Virgin Pulse Expand Partnership to Enhance Employer Offering03 Jul 2023
Headspace, a digital mental health company, and Virgin Pulse, an employer health tech company, have announced an extended partnership. Virgin... Continue Reading
|
GSK Completes $2B Acquisition of Bellus Health03 Jul 2023
GSK has completed its $2 billion acquisition of Canadian biotech company Bellus Health. The deal provides GSK with access to... Continue Reading
|
Luciole Medical AG Announces the Acquisition of Spiegelberg GmbH & Co. KG to Create a Leading Global Brain Monitoring Developer and Provider03 Jul 2023
Swiss medical technology company Luciole Medical has acquired Spiegelberg, a provider of specialized devices and consumables for neurosurgery, from SHS... Continue Reading
|
Oaktree Closes $2.3B Life Sciences Lending Fund03 Jul 2023
Oaktree Capital Management has successfully closed its Life Sciences Lending Fund, securing a record-breaking $2.3 billion capital commitment. The fund... Continue Reading
|
Shionogi Buys Qpex Biopharma for $140M, Expands Antimicrobial Pipeline03 Jul 2023
Shionogi has agreed to acquire Qpex Biopharma for a potential $140 million, gaining access to Qpex’s novel antimicrobial xeroborbactum. The... Continue Reading
|
Sobi Completes Acquisition of CTI BioPharma Corp.03 Jul 2023
Swedish Orphan Biovitrum AB (Sobi) has completed its acquisition of CTI BioPharma Corp. through its subsidiary Cleopatra Acquisition Corp. Sobi... Continue Reading
|